The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

Our previous studies have demonstrated that sorafenib can promote the dissemination of hepatocellular carcinoma (HCC) through downregulation of HTATIP2, a suppressor of tumor growth and metastasis that is associated with inhibition of angiogenesis. Here, we investigated the predictive values of the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Sun, Hui-Chuan, Wu, Chun-Tao, Zhu, Xiao-Dong, Zhang, Wei, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Tang, Zhao-You, Yu, Xian-Jun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2014
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116529/
https://ncbi.nlm.nih.gov/pubmed/25008315
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk